Results 1 to 10 of about 211,160 (222)
COL1A1::PDGFB fusion-associated uterine sarcoma and response to Imatinib: A case report
Gynecologic Oncology Reports, 2023 Uterine sarcomas are rare neoplasms of the uterus, some of which are associated with distinctive gene fusions. COL1A1::PDGFB fusion uterine sarcoma is a recently described entity that shares the same genetic alteration as dermatofibrosarcoma protuberans.
Udita Chapagain +4 more
doaj +1 more source
Current Issues in Molecular Biology, 2023 The benign tumor uterine leiomyoma (UL) develops from the smooth muscle tissue that constitutes the uterus, whereas malignant tumor uterine sarcoma develops from either the smooth muscle tissue or stroma and is different from UL and endometrial cancer ...
Takuma Hayashi +4 more
doaj +1 more source
Discover Oncology, 2023 Objectives To explore the correlation between tumor endothelial marker 1 (TEM1) and matrix metalloproteinase 2 (MMP-2) in uterine sarcoma and their roles in the progression of uterine sarcoma.
Chenghao Wu +5 more
doaj +1 more source
COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication
Gynecologic Oncology Reports, 2020 COL1A1-PDGFB gene fusion associated uterine sarcoma, so called dermatofibrosarcoma-like tumor, a recently reported entity in the uterine corpus, morphologically appears as high grade sarcoma with some features of dermatofibrosarcoma.
Samuel L. Grindstaff +5 more
doaj +1 more source
Cancer Medicine, 2022 Background The potential therapeutic benefit of adjuvant radiotherapy for patients with stage I uterine sarcoma has not been clear. In this study, we aimed to develop a risk scoring model to select the subgroup of patients with stage I uterine sarcoma ...
Yun‐xia Huang +8 more
doaj +1 more source
Journal of Education, Health and Sport, 2023 Introduction: Uterine leiomyosarcoma accounts for approximately 3%–7% of all uterine cancers and it is the most common subtype of uterine sarcoma.
Monika Pająk +4 more
doaj +1 more source
Treatment of uterine sarcomas [PDF]
Cancer, 1990 During a 21-year period, 66 patients with uterine sarcomas were treated at California Medical Center. Histological diagnoses were mixed mesodermal sarcoma in 32 patients (48%), leiomyosarcoma in 24 (36%), and endometrial stromal sarcoma in 10 (15%) patients. The majority of patients (73%) had Stage I tumors.
G, Echt +7 more
openaire +2 more sources
Impact on prognosis of unexpected uterine sarcoma with scalpel morcellation or enucleation
Gynecologic Oncology Reports, 2022 Objective: It is well known that power morcellation of unexpected uterine sarcoma affects prognosis. There are few reports on the effects of scalpel morcellation or myomectomy of uterine sarcoma on prognosis, which is not well understood.
Terumi Tanigawa +9 more
doaj +1 more source
Clinical characteristics of uterine sarcoma: Retrospective analysis of a single center
Medicine Science, 2021 To examine the histopathological features and treatment modalities in patients with uterine sarcoma according to subgroups (uterine leiomyosarcoma, low grade/high grade endometrial stromal sarcoma, adenosarcoma, undifferentiated uterine sarcoma) and to ...
Songul Alemdaroglu +5 more
doaj +1 more source
Taiwanese Journal of Obstetrics & Gynecology, 2020 Objective: To evaluate the risk of encountering unexpected uterine smooth muscle tumors of uncertain malignant potential (STUMPs) or sarcomas during surgical treatment of mesenchymal tumors of the uterus using morcellation.
Anthony Kyung Woo Han +7 more
doaj +1 more source